Label: FEMININE ANTI-ITCH CREME- benzocaine, resorcinol cream

  • NDC Code(s): 63868-949-01
  • Packager: Quality Choice (CHAIN DRUG MARKETING ASSOCIATION)
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 18, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts Active ingredients

    Benzocaine 20%

    Resorcinol 3%

  • Purpose

    External analgesic

  • Keep out of reach of children

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

  • Use

    temporarily relieves itching

  • Warnings

    For external use only

  • When using this product

    avoid contact with the eyes

  • Stop use and ask a doctor if

    condition worsens, or if symptoms persist for more than7 days or clear up and occur again within a few days

  • Do not apply Directions

    Do not apply over large area of the body.

    adults and children 12 years and older apply a fingertip amount (approximately 1-inch strip) to the affected area not more than 3 to 4 times daily

    children under 12 years ask a doctor

  • Other Information

    store at 20° -25° C (68° -77° F)

  • Inactive Ingredients

    aloe barbadensis leaf extract, carbomer, cetyl alcohol, cholecalciferol, glyceryl monostearate, isopropyl myristate, isopropyl palmitate, isopropyl sterate, lanolin, methylparaben, mineral iol, PEG-100 stearate, propylene glycol, purified water, retinyl palmitate, sodium hydroxide, sodium sulfite, tocopheryl acetate, trisodium HEDTA


  • Questions or comments?

    800-935-2362

  • Quality Choice Maximum Strength Feminine Anti-itch Cream

    label

  • INGREDIENTS AND APPEARANCE
    FEMININE ANTI-ITCH CREME 
    benzocaine, resorcinol cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-949
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE5.67 g  in 28 g
    RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK) RESORCINOL0.85 g  in 28 g
    Inactive Ingredients
    Ingredient NameStrength
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    CHOLECALCIFEROL (UNII: 1C6V77QF41)  
    GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
    ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)  
    ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)  
    ISOPROPYL STEARATE (UNII: 43253ZW1MZ)  
    LANOLIN (UNII: 7EV65EAW6H)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    SODIUM SULFITE (UNII: VTK01UQK3G)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    TRISODIUM HEDTA (UNII: K3E0U7O8KI)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:63868-949-0128 g in 1 TUBE; Type 0: Not a Combination Product02/01/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01702/01/2020
    Labeler - Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) (011920774)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!